Skip to main content
HRTX logo

HRTX · Heron Therapeutics, Inc. · Analyst Estimates

Track HRTX — free
$0.27 +0.01 (+2.23%) Play latest call Q2 2026 earnings call transcript
Market Cap
$50.25M
Shares
190.27M
Volume · Nov 19 3.61M Avg daily vol (3M) 4.54M

Analyst Estimates

Compare analyst forecasts for Heron Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-16 21:41 UTC · Publication dates shown per estimate · 7 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.15
-0.14
-0.12
2
-0.13
-0.13
-0.13
-0.13
1
1
0
0
Revenue
USD
Publication date not stated
139.10M
141.60M
144.10M
2
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.14
-0.12
-0.10
2
-0.11
-0.11
-0.11
-0.11
1
1
0
0
Revenue
USD
Publication date not stated
140.40M
140.40M
140.40M
1
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.03
-0.025
-0.02
2
-0.02
-0.02
-0.02
-0.02
1
1
0
0
Revenue
USD
Publication date not stated
31.50M
34.00M
36.50M
2
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
Revenue
analysts
Publication date not stated
— — —
0
— — — — — — — —
Key facts CIK 818033 CUSIP 427746102 13F (30d) 157 filings 141 filers Visit website Investor relations